NCT02502149 - Pharmacokinetics and Safety of rFVIIIFc Manufactured at 15,000 L (15K) Scale | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

April 30, 2017

Study Completion Date

June 30, 2017

Conditions

Severe Hemophilia A

Interventions

BIOLOGICAL

rFVIIIFc

As per arm description

Trial Locations (15)

Research Site, Grafton

Research Site, Camperdown

Research Site, Melbourne

Research Site, Hamilton

Research Site, Newtown

Research Site, Murdoch

Research Site, Christchurch

Research Site, Louisville

Research Site, Indianapolis

Research Site, East Lansing

Research Site, Chicago

Research Site, St Louis

Research Site, Salt Lake City

Research Site, Los Angeles

Research Site, Seattle